Results 161 to 170 of about 26,218 (217)

Maternal substance use disorder and neonatal health: epidemiologic and socioeconomic determinants in a case-control study, Shiraz, Iran. [PDF]

BMC Pregnancy Childbirth
Oboodi R, Barzegar H, Doostfatemeh M, Bahrami R, Zolfaghari S, Salehi A.   +5 more
europepmc   +1 more source

Repeated naloxone-induced morphine withdrawal alters blood brain barrier and blood spinal cord barrier integrity in mice. [PDF]

Mol Brain
Kohro Y, Brown CE, Trang T.
europepmc   +1 more source

Proceedings: Jumping behavior as a withdrawal syndrome in morphinized rats.

Japanese journal of pharmacology, 1974
H, Nakamura, Y, Yokoyama, M, Shimizu
openaire   +1 more source

Hyperbaric oxygen treatment attenuates naloxone-precipitated opioid withdrawal behaviors and alters microglial activity in male and female mice. [PDF]

Sci Rep
Southard MT, Giannotti G, Thakar A, Willsey TR, Bailey LG, Salazar F, Hentges S, Quock RM, Brown TE.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Influence of ω-conotoxin on morphine analgesia and withdrawal syndrome in rats

European Journal of Pharmacology, 1992
The effect of omega-conotoxin on opiate analgesia and withdrawal syndrome was investigated in rats. omega-Conotoxin given i.c.v. and i.p. caused weak analgesia in the tail-flick test. When the toxin (20 ng/rat) was given i.c.v. immediately before morphine (1.5 micrograms/rat i.c.v.) the resultant analgesic effect was additive.
Basilico L, PAROLARO, DANIELA, RUBINO, TIZIANA, Gori E, Giagnoni G.   +4 more
openaire   +6 more sources

Neurotransmitter Mechanisms of Morphine Withdrawal Syndrome

Bulletin of Experimental Biology and Medicine, 2009
Activity of the major neurotransmitter systems in the brainstem and cerebellum was studied in rats with morphine withdrawal syndrome. The most significant changes were found in the brainstem of animals by the 36th hour and 7 days after morphine withdrawal.
S V, Lelevich, V V, Lelevich, A A, Novokshonov   +2 more
openaire   +2 more sources

Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome

Pharmacology Biochemistry and Behavior, 1982
The effects of the alpha-2 adrenergic agonist, clonidine, on the "quasi-morphine withdrawal syndrome" (QMWS) were examined in drug naive rats. The QMWS was induced by combined systemic administration of iso-butyl-methylxanthine (IBMX: 15 mg/kg, IP) and naloxone (1 mg/kg, IP).
S J, Grant, D E, Redmond
openaire   +2 more sources

Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

European Journal of Pharmacology, 2002
We had previously found that co-injection of dextromethorphan, an antitussive drug and a non-competitive NMDA receptor antagonist, with morphine into dam rats throughout the pregnancy period could attenuate the naloxone-precipitated morphine withdrawal syndrome in their offspring.
Geng-Chang, Yeh, Pao-Luh, Tao, Julia Yi-Ru, Chen, Ming-Cherng, Lai, Fong-Shui, Gao, Chum-Lin, Hu   +5 more
openaire   +2 more sources

Disulfiram attenuates morphine or methadone withdrawal syndrome in mice

Behavioural Pharmacology, 2018
Taking opioids is often accompanied by the development of dependence. Unfortunately, treatment of opioid dependence is difficult, particularly because of codependence – for example, on alcohol or other drugs of abuse. In the presented study, we analyzed the potential influence of disulfiram, a drug used to aid the management of alcoholism, on opioid ...
Anna, de Cordé, Paweł, Krząścik, Renata, Wolińska, Patrycja, Kleczkowska, Małgorzata, Filip, Magdalena, Bujalska-Zadrożny   +5 more
openaire   +2 more sources